Hosted by King's Innovation Catalyst, this one hour webinar will explore the external innovation funding and academic engagement opportunities available through partnerships with global pharmaceutical company, Servier.

Guest speaker:

Emmanuel NONY, Ph.D., Director R&D External Innovation Europe, Servier Institute of Therapeutic Innovation.

The webinar is intended to be interactive, and will cover the following:

• Overview of Servier’s R&D priority areas
• Servier’s perspectives of the ‘challenges & solutions’ for optimal academic R&D collaboration,
• Outline of the aspects Servier considers when undertaking academic research collaborations and the various models for collaboration,
• Examples (on a non-confidential basis) of successful academic collaborations,
• Audience Q&A

This webinar is open to all within King’s and will be of particular relevance to researchers and associated teams in:

Oncology

• Precision Medicine (clear patient selection strategy in indications of high unmet need)
• Neuro-oncology (glioma / GBM)
• Gastrointestinal tumors e.g., colorectal, pancreatic, gastric cancers
• Haem-onc (The acute leukemias (AML / MDS, ALL)

Modalities

• small molecule targeted therapies, antibodies (mAb, ADC, bi-tri-specific, TCE) and oligonucleotides.

Neurology - Rare disorders with high unmet medical needs such as

• rare movement disorders (e.g., FA, SCA, MSA, PSP, HD)
• neuromuscular disorders (e.g., ALS, SMA, DMD, FSHD, DM, MG)
• refractory epilepsies (e.g., DS, LGS, JS, WS).